Other

Due after five years

Biogen Due after five years decreased by 12.1% to $10.90M in Q1 2026 compared to the prior quarter. Over 3 years (FY 2020 to FY 2025), Due after five years shows a downward trend with a -36.8% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2015
Last reportedQ1 2026
Metric ID: other_available_for_sale_securities_debt_maturities_afte_476e01

Historical Data

11 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q4 '25Q1 '26
Value$44.20M$42.80M$24.00M$18.70M$13.50M$12.00M$12.10M$16.60M$15.70M$12.40M$10.90M
QoQ Change-3.2%-43.9%-22.1%-27.8%-11.1%+0.8%+37.2%-5.4%-21.0%-12.1%
YoY Change-69.5%-72.0%-49.6%-11.2%+16.3%
Range$10.90M$44.20M
CAGR-42.9%
Avg YoY Growth-37.2%
Median YoY Growth-49.6%
Current Streak3 quarters decline

Frequently Asked Questions

What is Biogen's due after five years?
Biogen (BIIB) reported due after five years of $10.90M in Q1 2026.
What is the long-term trend for Biogen's due after five years?
Over 3 years (2020 to 2025), Biogen's due after five years has grown at a -36.8% compound annual growth rate (CAGR), from $49.20M to $12.40M.